The objectives is to compare the changes in body composition (primary objective), diabetes
parameters, energy expenditure and energy intake between Insulin detemir (Levemir® - Novolin®
4 pen) and insulin glargine (Lantus® - Solostar®) both in combination with Metformin and
insulin secretagogues (SU) between baseline and after 6 months of insulin therapy in 80 type
2 diabetic patients failing on oral diabetic agents .